Form 4: Baxter International EVP Heather Knight Reports Stock Transactions

EVP and Chief Operating Officer of Baxter International, Heather Knight, reports acquisition and disposal of company stock and stock options.

Summary

• Heather Knight, EVP and Chief Operating Officer of Baxter International, filed a Form 4 detailing changes in beneficial ownership.
• On March 6, 2025, Knight forfeited 13,634 shares to cover tax withholdings related to the settlement of vested restricted stock units at a price of $35.44.
• On the same date, she received a grant of 35,674 restricted stock units, vesting in three equal annual installments starting March 6, 2026.
• Knight also received options to purchase 118,934 shares of common stock at an exercise price of $35.44, which become exercisable in three equal annual installments beginning March 6, 2026.
• Following these transactions, Knight beneficially owns 177,362 shares of Baxter International common stock and 118,934 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports routine stock transactions by an executive. The grants of stock options and restricted stock units are generally viewed as positive incentives, but the forfeiture of shares for tax purposes is a neutral event.

Positives

• The grant of restricted stock units and stock options to a key executive like Heather Knight could be seen as a positive incentive for future performance.

Future Outlook

The restricted stock units and stock options vest in the future, contingent on continued employment and satisfaction of the vesting requirements outlined in the Baxter International Inc. 2021 Incentive Plan.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are common in the healthcare industry to align management's interests with those of shareholders.
• Companies like Medtronic, Johnson & Johnson, and Abbott Laboratories also utilize similar equity-based compensation plans for their executives.
• The vesting schedules and exercise prices are generally in line with industry norms, designed to incentivize long-term value creation.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect changes in the ownership stake of a key executive.
• Employees may view the equity grants as a positive sign of the company's commitment to its leadership team.

Key Dates